The initiation of beta-blockers in the perioperative period of non-cardiac surgery remains controversial. After reviewing all the evidence, the expert panel of the Chinese Society of Cardiology (CSC) believes that there lacks high-quality randomized trial and the use of perioperative beta-blocker can only be considered on a case-by-case basis. Five practical recommendations are presented.
通讯机构:[1]Peking Univ, Hosp 1, Dept Cardiol, Beijing 100034, Peoples R China;[23]Peking Univ, Hosp 1, Dept Cardiol, 8 Xishiku St, Beijing 100034, Peoples R China
推荐引用方式(GB/T 7714):
Huo Yong,Shi Zhongwei,Chen Yundai,et al.Expert panel of the Chinese Society of Cardiology recommendations on beta-blocker therapy in patients undergoing non-cardiac surgery[J].EUROPEAN HEART JOURNAL SUPPLEMENTS.2015,17(F):F1-F3.doi:10.1093/eurheartj/suv048.
APA:
Huo, Yong,Shi, Zhongwei,Chen, Yundai,Dong, Yugang,Ge, Junbo...&Zhu, Wenling.(2015).Expert panel of the Chinese Society of Cardiology recommendations on beta-blocker therapy in patients undergoing non-cardiac surgery.EUROPEAN HEART JOURNAL SUPPLEMENTS,17,(F)
MLA:
Huo, Yong,et al."Expert panel of the Chinese Society of Cardiology recommendations on beta-blocker therapy in patients undergoing non-cardiac surgery".EUROPEAN HEART JOURNAL SUPPLEMENTS 17..F(2015):F1-F3